Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

April 25, 2019 by Alan Khadavi

Cold Hives (urticaria): A review

cold hives

Cold hives (or urticaria), is a subtype of physical hives that is characterized by the development of hives and swelling in response to cold exposure and rewarming of the skin.  It is related to the histamine release of mast cells.  Several studies have shown that it is related to IgE and an unknown skin autoallergen […]

Filed Under: angioedema, Blog, hives, Urticaria

April 22, 2019 by Alan Khadavi

Can Asthma cause Postpartum Depression?

postpartum depression

Can asthma cause postpartum depression? Asthma is one of the most common chronic diseases that can complicate pregnancy. It can put women at increased risk of pregnancy outcomes. Postpartum depression is a nonpsychotic depressive episode that begins after delivery, most occur 1 to 3 months after delivery, but its onset may occur as late as […]

Filed Under: Asthma, Blog

April 10, 2019 by Alan Khadavi

Gut microbiome in food allergy

ibs and food allergy

The gut microbiome (bacteria) can play a strong role in food allergies. Food allergy is a clinical and public health problem that affects up to 10% of the US population.  It is defined as an adverse health effect arising from a specific immune response that occurs on exposure to a food.  IgE food mediated allergy […]

Filed Under: Blog, Food allergy, Headlines

April 8, 2019 by Alan Khadavi

New Sublingual Tree Tablet

sublingual tree tablet

A new sublingual tree tablet is currently being developed for the treatment of tree pollen induced allergic rhinoconjunctivitis.  Allergic rhinitis is estimated to affect 500 million individuals worldwide and is considered a global health problem.  It leads to lower school and work performance.  Allergic rhinitis is also a risk factor for asthma development. Currently allergy […]

Filed Under: Allergy Medicine, Blog, Medications

March 28, 2019 by Alan Khadavi

Can you outgrow seafood allergy?

There have not been many studies to see whether someone can outgrow seafood allergy unlike peanut allergy where 20% is considered the norm.  Can you outgrow peanut allergy? Seafood allergy includes allergy to either fish or shellfish although the main allergenic proteins differ between these groups.  Worldwide prevalence of allergy to fish is reported to […]

Filed Under: Blog, Food allergy

March 13, 2019 by Alan Khadavi

Ryaltris Nasal Spray for Allergic Rhinitis

ryaltris

Ryaltris is a new nasal spray (formerly GSP301) that is being investigated by Glenmark Pharmaceuticals for the treatment of seasonal allergic rhinitis in patients 12 years and older.  Ryaltris consists of 2 drugs, the first one is olopatadine hydrochloride, a nasal antihistamine, which is the medication used in Patanase nasal spray.   The second medication […]

Filed Under: Blog, Medications

March 4, 2019 by Alan Khadavi

Tree Nut Allergy: Is it the new Peanut Allergy?

tree nut allergy

Tree nut allergy is usually lifelong and together with peanut allergy are the most common cause of food induced anaphylaxis. There is not as much data compared to peanut allergy. Children with peanut allergy are thought to be at increased risk of tree nut allergies, with around 30% of pediatric patients presenting with peanut allergy […]

Filed Under: Blog, Food allergy

February 20, 2019 by Alan Khadavi

Adult Eczema: A Clinical Review

opzelura vs zoryve

Approximately 1 in 4 adults report the onset of adult eczema and the rest its onset is from childhood.  Eczema is an ill-defined skin lesions and it includes patches, papules, and plaques with different degrees of redness and swelling.  It can affect any skin site but they most classically affect the creases of the elbows […]

Filed Under: atopic dermatitis, Blog

February 7, 2019 by Alan Khadavi

Fezakinumab an IL-22 antagonist for Eczema

fezakinumab

IL-22 upregulation characterizes atopic dermatitis lesions.  However, blocking IL-22 has not been defined in human subjects.  A recent study sought to evaluate the cellular and molecular effects of fezakinumab (anti-IL-22) versus placebo taken from biopsy specimens. Atopic dermatitis is the most common chronic inflammatory skin disease with increasing prevalence.  IL-4 and IL-13 are the 2 […]

Filed Under: atopic dermatitis, biologics, Blog

February 5, 2019 by Alan Khadavi

Adbry Tralokinumab for Atopic Dermatitis

rhapsido

Adbry Tralokinumab is a fully human monclonal IgG4 antibody that potently and specifically neutralizes IL-13.  IL-13 has an important role in atopic dermatitis pathogenesis. Atopic dermatitis (eczema) is a chronic inflammatory skin disease.  It can affect sleep, psychosocial activities and health related quality of life.  The symptoms of many patients are not controlled with current […]

Filed Under: atopic dermatitis, biologics, Blog

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page